Less regulation of weight-loss drug would make Wegovy accessible to more people
Ministers are launching a £40m pilot scheme to trial wider access to the controversial slimming jab Wegovy, to examine how people could receive the drug outside hospitals.
Under current advice from the National Institute for Health and Care Excellence drugs regulator, Wegovy is only given via specialist weight management services, usually based in hospitals.
More Stories
AI learns to distinguish between aromas of US and Scottish whiskies
Esports are booming in Africa – but can its infrastructure keep pace?
How 2024 made Elon Musk the world’s most powerful unelected man